Presenting author

Carlos Zarate

1 presentation

• Clinical development of (2R,6R)-hydroxynorketamine: Ongoing trials in TRD and OCD and phase 1 safety, tolerability, and PK/PD results in healthy volunteers

  2026 ASCP Annual Meeting